Hello, I am Dr. Hidenori Shimada of Grand Green Osaka Umekita Clinic in Osaka, Japan.
Considering NK cell therapy is a significant step in exploring your cancer treatment options. For those looking into medical care in Japan, the first consultation is a crucial opportunity to gather information and understand if this approach is right for you. Proper preparation can help you make the most of this important conversation with your physician. This article provides a guide on what to ask and what information to bring to your first NK cell therapy consultation.
Why Preparation Matters for Your Consultation
A consultation for an advanced therapy like NK cell therapy can feel overwhelming. You may have many questions about the treatment process, its potential role alongside standard therapies, and the logistics of receiving care in Japan. Without preparation, it’s easy to forget key questions or miss the chance to provide your doctor with a complete picture of your health. A well-prepared consultation ensures a more productive dialogue, helps manage expectations, and empowers you to be an active participant in your healthcare decisions. It allows the physician to provide a more tailored assessment based on your specific medical history and goals.
Understanding NK Cell Therapy: The Basics
Before your appointment, it’s helpful to have a basic understanding of NK cell therapy. This form of immunotherapy utilizes your body’s own Natural Killer (NK) cells, a type of white blood cell that plays a key role in the innate immune system. These cells are able to identify and attack abnormal cells, such as cancer cells, without prior sensitization.
In this therapy, a sample of your blood is drawn to isolate your NK cells. These cells are then activated and expanded in number in a specialized laboratory facility. Finally, the enhanced population of your own NK cells is returned to your body through an intravenous (IV) infusion. The goal is to bolster your immune system’s ability to fight disease. It is often considered as an option that can be used in conjunction with standard treatments like chemotherapy, radiation, or surgery, not as a replacement for them. It’s important to remember that this is an elective, out-of-pocket treatment, and its suitability must be determined by a physician.
Key Questions to Ask Your Doctor
Having a list of questions ready can help structure your consultation. Consider organizing them into categories to ensure you cover all your concerns.
- About the Treatment Plan:
- Based on my diagnosis and medical history, am I a suitable candidate for NK cell therapy?
- What are the potential goals of this therapy in my specific case (e.g., supporting standard treatment, managing recurrence risk)?
- What does a typical treatment schedule look like? How many infusions are generally suggested and over what period?
- How would this therapy be coordinated with my current or planned standard cancer treatments?
- Regarding Efficacy and Risks:
- What are the potential side effects or risks associated with this treatment? While it uses my own cells, what should I be aware of?
- How will my condition be monitored during the treatment period?
- Are there any lifestyle or dietary considerations I should be aware of during treatment?
- About Costs and Logistics:
- Could you provide an estimate of the total cost for the recommended treatment plan?
- What services are included in this cost (e.g., consultations, cell processing, infusions)?
- For international patients, what is the expected duration of stay in Japan required for the treatment course?
Information to Bring to Your Appointment
To help the physician make an accurate assessment, it is essential to provide comprehensive medical information. If your documents are not in English or Japanese, it is highly recommended to have them translated.
- Medical Records: A summary of your diagnosis, including the type of cancer, stage, and pathology reports.
- Treatment History: Detailed information on all past and current cancer treatments, including surgery dates, chemotherapy drug names and cycles, and radiation therapy fields and doses.
- Recent Imaging: Reports from recent CT, MRI, or PET scans. Bringing the images themselves (e.g., on a CD) can also be beneficial.
- Recent Blood Tests: Results from recent lab work, including complete blood counts and tumor markers.
- List of Medications: A complete list of all prescription medications, over-the-counter drugs, and supplements you are currently taking.
- Allergy Information: A list of any known allergies to medications or other substances.
Consulting with a Specialist in Japan
In Japan, cell therapies like NK cell therapy are provided under the Act on the Safety of Regenerative Medicine. This means that treatments are offered by medical institutions that have submitted their treatment plans to and had them accepted by the Ministry of Health, Labour and Welfare. This framework ensures that cell processing and treatment administration adhere to national standards for safety management.
At Grand Green Osaka Umekita Clinic, located conveniently in the Umeda area of Osaka, our physicians are available to provide consultations for NK cell therapy. We welcome inquiries from patients both within Japan and from overseas. The decision to proceed with any treatment is made only after a thorough consultation with a doctor, where your individual health status, treatment goals, and any concerns you may have are carefully discussed. For more detailed information about our approach, fees, and the treatment process, please review our NK cell therapy page.
Learn more about NK Cell Therapy at Grand Green Osaka Umekita Clinic.
Conclusion
Your first consultation is a vital step toward understanding if NK cell therapy is a suitable option for you. By preparing your questions and organizing your medical information beforehand, you can facilitate a clear and comprehensive discussion with your doctor. This proactive approach helps ensure that you leave the appointment with a better understanding of the potential path forward, empowering you to make an informed decision about your care. Remember, any final treatment plan should be based on the professional judgment of a physician after a direct medical consultation.
- Understand the TherapyLearn the basics of NK cell therapy
- Prepare QuestionsFor treatment plan, risks, and costs
- Gather Medical InfoRecords, treatment history, test results
This diagram summarizes the key points from the article
References
- PubMed: CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors. (2024)
- PubMed: Exploring the NK cell platform for cancer immunotherapy. (2021)
- PubMed: Iron Chelation Therapy Elicits Innate Immune Control of Metastatic Ovarian Cancer. (2024)
- PubMed: Augmenting NK cell-based immunotherapy by targeting mitochondrial apoptosis. (2022)
- PubMed: Allogeneic natural killer cell therapy. (2023)
- PMC: Exploring the NK cell platform for cancer immunotherapy. (2021)
- PMC: Potential therapeutic roles of natural killer cells in acute myeloid leukemia: a systematic review study. (2025)
- PMC: Challenges to the broad application of allogeneic natural killer cell immunotherapy of cancer. (2022)
- MHLW (Japan): Regenerative Medicine — Ministry of Health, Labour and Welfare, Japan
Supervising Physician
Director, Medical Corporation Shimada Clinic
Head of Clinical Practice, Grand Green Osaka Umekita Clinic
Hidenori Shimada
Graduated from the University of Tokushima Faculty of Medicine in 2005. After his initial residency, he obtained U.S. medical certification (ECFMG) and trained as a sub-intern in general surgery at the University of Washington. After completing the doctoral program at Kyoto University Graduate School of Medicine and working as a researcher at the Center for iPS Cell Research and Application (CiRA), Kyoto University, he founded Shimada Clinic in 2013. At Grand Green Osaka Umekita Clinic (https://umekitaclinic.org), he is engaged in a wide range of care, from internal medicine and pediatrics to cell therapy and aesthetic medicine.
* The physician supervision of this article covers its academic content only and does not constitute a recommendation of any specific treatment or product.